| http://www.w3.org/ns/prov#value | - A glycolic extract of Potentilla erecta will preferably be used in the compositions of the present invention at a concentration of between 0.1 and 2% by weight.3) magnesium aspartate, at a concentration preferably of between 0.01 and 0.5% and particularly preferably of between 0.02 and 0.1% by weight, based on the composition.4) peptides for slowing down the release of neuromediators and capable o
|
